Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nalini Bora

Concepts (240)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis, Anterior
10
2019
28
3.300
 Why?
Autoimmune Diseases
11
2019
101
3.250
 Why?
Choroidal Neovascularization
17
2022
54
3.230
 Why?
Complement System Proteins
7
2014
46
1.950
 Why?
Macular Degeneration
10
2016
47
1.920
 Why?
Disease Models, Animal
22
2022
1458
1.800
 Why?
Autoantigens
5
2009
60
1.280
 Why?
Complement Activation
8
2010
42
1.260
 Why?
Uveitis
5
2009
29
1.080
 Why?
Rats, Inbred Lew
13
2019
69
1.080
 Why?
Immune Tolerance
6
2009
95
1.060
 Why?
Animals
41
2022
13246
0.910
 Why?
Transforming Growth Factor beta2
5
2019
17
0.870
 Why?
Rats
16
2019
3299
0.770
 Why?
Choroid
5
2012
24
0.710
 Why?
Geographic Atrophy
2
2016
7
0.670
 Why?
Complement Factor B
2
2011
10
0.660
 Why?
Complement Pathway, Alternative
2
2011
9
0.660
 Why?
Antigens, Surface
3
2010
54
0.650
 Why?
T-Lymphocytes, Regulatory
2
2009
86
0.650
 Why?
Eye Diseases
3
2008
38
0.640
 Why?
Recombinant Proteins
4
2019
487
0.620
 Why?
Adiponectin
6
2022
64
0.600
 Why?
CD4-Positive T-Lymphocytes
2
2011
164
0.600
 Why?
Complement Membrane Attack Complex
6
2011
19
0.570
 Why?
Eye
4
2006
32
0.570
 Why?
Collagen Type I
2
2009
88
0.550
 Why?
Antigens, Neoplasm
2
2008
152
0.500
 Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
595
0.490
 Why?
Neovascularization, Pathologic
3
2012
162
0.480
 Why?
Lasers
8
2011
123
0.480
 Why?
Ethanol
3
2008
341
0.470
 Why?
Blotting, Western
6
2016
601
0.460
 Why?
Complement C4
2
2011
9
0.450
 Why?
Interleukin-2 Receptor alpha Subunit
2
2009
9
0.430
 Why?
Male
25
2020
25399
0.410
 Why?
Mice
16
2022
5759
0.410
 Why?
Receptors, Cell Surface
2
2010
125
0.410
 Why?
Honey
1
2011
8
0.390
 Why?
Keratitis
1
2011
12
0.390
 Why?
Adoptive Transfer
5
2011
40
0.390
 Why?
Pseudomonas Infections
1
2011
48
0.380
 Why?
Eye Injuries
1
2011
27
0.380
 Why?
Eye Infections, Bacterial
1
2011
31
0.380
 Why?
Wound Healing
2
2016
205
0.380
 Why?
Models, Biological
1
2014
723
0.380
 Why?
Vascular Endothelial Growth Factor A
8
2016
202
0.380
 Why?
Down-Regulation
3
2007
349
0.370
 Why?
Complement C3
4
2014
24
0.370
 Why?
Complement Factor H
2
2010
10
0.370
 Why?
Mice, Inbred C57BL
11
2020
1819
0.370
 Why?
Cell Proliferation
6
2020
1013
0.360
 Why?
Protein Processing, Post-Translational
2
2009
171
0.360
 Why?
Apoptosis
5
2014
1112
0.360
 Why?
Enzyme-Linked Immunosorbent Assay
5
2016
244
0.360
 Why?
Mice, Knockout
5
2016
846
0.340
 Why?
Epitopes
1
2009
61
0.340
 Why?
Complement Inactivator Proteins
2
2006
5
0.330
 Why?
Immunohistochemistry
5
2014
978
0.310
 Why?
Wet Macular Degeneration
2
2022
12
0.310
 Why?
Cattle
4
2009
219
0.310
 Why?
Acyltransferases
2
2006
29
0.300
 Why?
Complement C3b
2
2006
7
0.290
 Why?
Retinal Pigment Epithelium
3
2016
18
0.280
 Why?
Esters
1
2006
22
0.270
 Why?
Immunity, Innate
1
2007
105
0.260
 Why?
Angiogenesis Inhibitors
2
2020
188
0.260
 Why?
Fatty Acids
1
2006
145
0.250
 Why?
Lipoxygenase Inhibitors
1
2005
6
0.250
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.250
 Why?
Cyclooxygenase Inhibitors
1
2005
39
0.250
 Why?
Nitric Oxide Synthase
1
2005
75
0.250
 Why?
Immunologic Factors
1
2006
114
0.250
 Why?
Antigens, CD
2
2003
221
0.250
 Why?
Carboxylic Ester Hydrolases
1
2003
7
0.230
 Why?
Injections, Intravenous
3
2009
143
0.230
 Why?
Mutagenesis, Site-Directed
1
2003
99
0.230
 Why?
Avian Proteins
1
2003
4
0.220
 Why?
Antigen-Presenting Cells
1
2003
26
0.220
 Why?
Blood Proteins
1
2003
82
0.210
 Why?
Polyethylene Glycols
2
2014
93
0.210
 Why?
Cytokines
3
2011
613
0.200
 Why?
Injections, Intraocular
2
2019
6
0.200
 Why?
Myocardium
1
2003
438
0.190
 Why?
Trabeculectomy
1
2020
10
0.190
 Why?
Trityl Compounds
1
2020
2
0.180
 Why?
Butyric Acid
1
2020
10
0.180
 Why?
Acetamides
1
2020
20
0.180
 Why?
Glaucoma
1
2020
34
0.180
 Why?
Transforming Growth Factor beta
3
2006
144
0.170
 Why?
Peptide Fragments
2
2012
213
0.170
 Why?
Endotoxins
2
2011
34
0.170
 Why?
Nicotine
2
2012
187
0.170
 Why?
Melanins
2
2011
27
0.160
 Why?
Specific Pathogen-Free Organisms
2
2009
18
0.160
 Why?
Immunoglobulin G
2
2011
186
0.160
 Why?
Thalidomide
1
2020
377
0.150
 Why?
RNA, Small Interfering
3
2010
215
0.150
 Why?
Pigment Epithelium of Eye
2
2010
8
0.150
 Why?
Humans
16
2022
50208
0.150
 Why?
Lymph Nodes
2
2009
263
0.140
 Why?
Gene Expression Regulation
3
2014
979
0.140
 Why?
T-Lymphocytes
1
2019
339
0.140
 Why?
Retinal Degeneration
1
2016
11
0.130
 Why?
Alcohol Drinking
2
2008
226
0.130
 Why?
Chemokine CCL2
2
2016
71
0.130
 Why?
RNA, Messenger
3
2010
1108
0.130
 Why?
Amino Acid Sequence
3
2009
586
0.120
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2016
122
0.120
 Why?
Aspirin
1
2016
114
0.120
 Why?
Photoreceptor Cells, Vertebrate
1
2014
3
0.120
 Why?
Peptides
2
2022
223
0.110
 Why?
Follow-Up Studies
2
2011
2190
0.110
 Why?
In Situ Nick-End Labeling
2
2014
57
0.100
 Why?
Vascular Endothelial Growth Factors
1
2012
15
0.100
 Why?
Molecular Sequence Data
2
2004
793
0.100
 Why?
Receptors, Adiponectin
3
2022
10
0.100
 Why?
Membrane Glycoproteins
2
2003
246
0.100
 Why?
Proliferating Cell Nuclear Antigen
3
2022
75
0.100
 Why?
Administration, Topical
1
2011
56
0.100
 Why?
Cornea
1
2011
52
0.100
 Why?
Pseudomonas aeruginosa
1
2011
72
0.090
 Why?
Lipoproteins, LDL
1
2012
170
0.090
 Why?
Endothelium, Vascular
1
2012
254
0.090
 Why?
Drug Carriers
1
2011
71
0.090
 Why?
Fluorescent Antibody Technique
1
2010
113
0.090
 Why?
Antibodies, Monoclonal, Humanized
1
2012
225
0.090
 Why?
RNA
1
2011
171
0.090
 Why?
Autoantibodies
1
2011
116
0.090
 Why?
Microscopy, Confocal
3
2005
89
0.090
 Why?
Lymphocyte Depletion
1
2009
8
0.090
 Why?
Immunization
1
2009
67
0.080
 Why?
Cell Membrane
1
2010
251
0.080
 Why?
Forkhead Transcription Factors
1
2009
112
0.080
 Why?
Lymphocyte Count
1
2008
22
0.080
 Why?
Interleukin-2
1
2008
72
0.080
 Why?
Coculture Techniques
1
2008
146
0.080
 Why?
Treatment Outcome
2
2011
5155
0.080
 Why?
Caspase 8
1
2007
12
0.080
 Why?
Caspase 9
1
2007
15
0.080
 Why?
Diet
2
2016
557
0.080
 Why?
Cytochromes c
1
2007
29
0.080
 Why?
Cell Line
3
2020
1021
0.080
 Why?
bcl-2-Associated X Protein
1
2007
56
0.070
 Why?
Caspase 3
1
2007
97
0.070
 Why?
Growth Substances
1
2007
23
0.070
 Why?
Anterior Chamber
1
2007
8
0.070
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
129
0.070
 Why?
Complement C5
1
2006
3
0.070
 Why?
Complement C1q
1
2006
9
0.070
 Why?
Receptors, Complement
1
2006
3
0.070
 Why?
Complement C3-C5 Convertases
1
2006
3
0.070
 Why?
Oligodeoxyribonucleotides, Antisense
1
2006
4
0.070
 Why?
Antibodies, Blocking
1
2006
8
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2007
105
0.070
 Why?
Cyclin E
1
2006
6
0.070
 Why?
Cyclin-Dependent Kinase 2
1
2006
16
0.070
 Why?
Macrophage-1 Antigen
1
2006
9
0.070
 Why?
Fluorescent Antibody Technique, Indirect
1
2006
21
0.070
 Why?
Inflammation
1
2010
604
0.070
 Why?
Recombinant Fusion Proteins
1
2007
186
0.070
 Why?
Risk Factors
1
2014
3629
0.070
 Why?
Chemokines
1
2006
78
0.070
 Why?
Models, Molecular
1
2007
341
0.070
 Why?
Cell Adhesion Molecules
1
2006
89
0.070
 Why?
Arachidonate 5-Lipoxygenase
1
2005
4
0.060
 Why?
Collagen
1
2007
207
0.060
 Why?
Cyclooxygenase 2 Inhibitors
1
2005
19
0.060
 Why?
Guanidines
1
2005
31
0.060
 Why?
Injections, Subcutaneous
1
2005
54
0.060
 Why?
Nitric Oxide Synthase Type II
1
2005
66
0.060
 Why?
Cyclooxygenase 2
1
2005
45
0.060
 Why?
Flow Cytometry
1
2007
476
0.060
 Why?
Macrophages
1
2007
363
0.060
 Why?
Fibroblast Growth Factors
1
2005
47
0.060
 Why?
Up-Regulation
1
2006
453
0.060
 Why?
Immune Sera
1
2004
17
0.060
 Why?
Organ Specificity
1
2004
108
0.060
 Why?
Pyrazoles
1
2005
114
0.060
 Why?
Sequence Homology
1
2003
20
0.060
 Why?
COS Cells
1
2003
74
0.060
 Why?
Sulfonamides
1
2005
128
0.060
 Why?
Bruch Membrane
1
2003
1
0.060
 Why?
Enzyme Activation
1
2003
275
0.050
 Why?
Hypersensitivity, Delayed
1
2003
21
0.050
 Why?
Disease Progression
1
2006
831
0.050
 Why?
Interleukin-12
1
2003
31
0.050
 Why?
Fluorescein-5-isothiocyanate
1
2022
9
0.050
 Why?
Ophthalmic Solutions
1
2022
19
0.050
 Why?
Interleukin-10
1
2003
84
0.050
 Why?
Structure-Activity Relationship
1
2003
401
0.050
 Why?
Antibodies, Monoclonal
1
2006
460
0.050
 Why?
Cells, Cultured
3
2012
1581
0.050
 Why?
Antibodies, Neutralizing
2
2012
64
0.050
 Why?
Time Factors
3
2014
2922
0.050
 Why?
Tetrazolium Salts
1
2020
14
0.050
 Why?
Immunotherapy
1
2003
240
0.050
 Why?
Rats, Inbred BN
2
2012
17
0.050
 Why?
Mitomycin
1
2020
20
0.050
 Why?
Lidocaine
1
2020
50
0.040
 Why?
Human Umbilical Vein Endothelial Cells
1
2020
90
0.040
 Why?
Aging
1
2004
688
0.040
 Why?
Endothelial Cells
2
2012
270
0.040
 Why?
Mutation
1
2003
1294
0.040
 Why?
Immunoenzyme Techniques
2
2010
145
0.040
 Why?
Female
1
2016
26635
0.030
 Why?
Complement C1 Inhibitor Protein
1
2014
3
0.030
 Why?
Aminopeptidases
1
2014
17
0.030
 Why?
Matrix Metalloproteinase 9
1
2014
89
0.030
 Why?
Serine Endopeptidases
1
2014
52
0.030
 Why?
Autophagy
1
2014
169
0.030
 Why?
Bungarotoxins
1
2012
6
0.030
 Why?
Intravitreal Injections
1
2012
35
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
 Why?
Aged
2
2022
9405
0.030
 Why?
Receptors, Nicotinic
1
2012
76
0.020
 Why?
Oxidation-Reduction
1
2012
320
0.020
 Why?
Complement C9
1
2011
3
0.020
 Why?
Polymerase Chain Reaction
1
2012
454
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
411
0.020
 Why?
Analysis of Variance
1
2012
564
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1378
0.020
 Why?
Vision, Ocular
1
2010
11
0.020
 Why?
Transcriptome
1
2012
320
0.020
 Why?
Gene Expression
1
2012
609
0.020
 Why?
Protein Structure, Tertiary
1
2009
253
0.020
 Why?
Models, Animal
1
2009
232
0.020
 Why?
Immune System
1
2004
43
0.010
 Why?
Immunoblotting
1
2003
117
0.010
 Why?
Thromboplastin
1
2003
6
0.010
 Why?
Gene Library
1
2003
43
0.010
 Why?
Cell Adhesion
1
2003
158
0.010
 Why?
Adenoviridae
1
2003
51
0.010
 Why?
DNA, Complementary
1
2003
135
0.010
 Why?
Genetic Vectors
1
2003
125
0.010
 Why?
Retina
1
2003
65
0.010
 Why?
Swine
1
2003
396
0.010
 Why?
Protein Binding
1
2003
665
0.010
 Why?
Liver
1
2003
1116
0.010
 Why?
Middle Aged
1
2003
12206
0.000
 Why?
Bora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (240) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (38) people
_
Same Department Expand Description
Search Department